Estrella Immunopharma, Inc. (ESLA)
NASDAQ: ESLA · Real-Time Price · USD
1.230
-0.070 (-5.38%)
At close: Oct 9, 2025, 4:00 PM EDT
1.230
0.00 (0.00%)
After-hours: Oct 9, 2025, 4:00 PM EDT
Estrella Immunopharma Market Cap
Estrella Immunopharma has a market cap or net worth of $46.33 million as of October 9, 2025. Its market cap has increased by 31.31% in one year.
Market Cap
46.33M
Enterprise Value
45.76M
1-Year Change
31.31%
Ranking
Category
Stock Price
$1.23
Market Cap Chart
Since October 19, 2022, Estrella Immunopharma's market cap has increased from $1.78M to $46.33M, an increase of 2,506.43%. That is a compound annual growth rate of 199.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 8, 2025 | 48.19M | 10.99% |
| Dec 31, 2024 | 43.41M | 11.11% |
| Dec 29, 2023 | 39.07M | 441.69% |
| Dec 30, 2022 | 7.21M | 305.79% |
| Oct 19, 2022 | 1.78M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |